'4-Aminoquinazoline-6,7-diol' derivatives for enhanced EGFR binding (as inhibitor) against Lung cancer
The paper evaluates four 4-aminoquinazoline-6,7-diol derivatives as potential EGFR inhibitors for lung cancer, showing varying cytotoxicity and kinase inhibition effects.
bioRxiv · Feb 14, 2022 · PreprintBioinformatics